Skip to content
mapperlab
← Dashboard
Stock

IPAR

INTERPARFUMS, INC.
Consumer StaplesHousehold ProductsLatest close $878 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
8
27 funds tracked
Ever held
10
Current + past
New this quarter
1
Exited this quarter
0

Marquee-fund ownership over time

Aug 14, 2019Aug 14, 2024Aug 14, 2025May 15, 2026
Now
8

This quarter's activity

New positions opened

Positions exited

None.

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Bridgewater Associates re-entered$66$87+32%
Citadel Advisors$118$87-26%
D.E. Shaw re-entered$118$87-26%
AQR Capital Management$118$87-26%
Millennium Management re-entered$118$87-26%
Two Sigma Investments$86$87+2%
Point72 Asset Management$86$87+2%
Maverick Capital$86$87+1%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
Renaissance Technologies→ $123-1%
Coatue Management→ $67+17%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at INTERPARFUMS INC. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
1
Filings · last 90d
13
Total on file
572
Recent SEC buffer
Most recent
Apr 3, 2026

30d / 90d windows measured from Apr 3, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 572 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · INTERPARFUMS, INC.

Annual figures sourced directly from INTERPARFUMS, INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Revenue
$1.49B
FY2025+2% YoY
Net income
$168.39M
FY2025+2% YoY
EPS (diluted)
$5.24
FY2025+2% YoY
Free cash flow(?)
$190.49M
FY2025+4% YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for INTERPARFUMS INC — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Maverick CapitalQ2 2026open$86$92+7%
Two Sigma InvestmentsQ4 2025open$86$87+2%
D.E. ShawQ4 2025open$86$87+2%
Point72 Asset ManagementQ4 2025open$86$87+2%
Bridgewater AssociatesQ4 2025open$86$92+7%
Millennium ManagementQ3 2025open$112$87-22%
Citadel AdvisorsQ3 2024open$118$87-26%
D.E. ShawQ3 2024Q3 2025$118$112-5%
AQR Capital ManagementQ3 2024open$118$87-26%
Millennium ManagementQ3 2024Q2 2025$118$121+3%
Renaissance TechnologiesQ3 2024Q4 2024$125$123-1%
Bridgewater AssociatesQ3 2021Q2 2025$66$120+82%
Coatue ManagementQ3 2019Q4 2019$57$67+17%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.